Information icon

Save £15 on Weight Loss over £80 | Use Code WL15

Weight Loss
Complete our online consultation to start treatment in 4 simple & secure steps.
3 minute online consultation form
1. 3 minute online consultation form
Choose & pay for your medication
2. Choose & pay for your medication
Upload images for clinical review
3. Upload images for clinical review
Same day dispatch (order before 1pm)
4. Same day dispatch (order before 1pm)
  • UK-registered clinical team
    UK-registered clinical team
  • Confidential & secure
    Confidential & secure
  • No GP visit needed
    No GP visit needed
  • Fast & discreet delivery
    Fast & discreet delivery
Mysimba 112 Tablets Rear view of Mysimba Tablets (90mg)

Mysimba Tablets (90mg)

Mysimba Tablets (90mg) Product information

£109.98

You need to complete a consultation before you can purchase this product.

Buy Mysimba Online in the UK

Mysimba is a prescription weight loss tablet containing two medicines: Naltrexone and Bupropion. It works on parts of the brain involved in appetite and food reward, helping to reduce how much you eat. When used alongside a reduced-calorie diet and increased physical activity, it supports weight loss.

You can buy Mysimba online in the UK from Oxford Online Pharmacy following a short online consultation. One of our independent doctors will assess whether Mysimba is a safe and suitable weight loss treatment for you before it’s dispensed from our pharmacy to your front door.

Product Information for Mysimba Tablets (90mg)

What is Mysimba?

Mysimba is a prescription medicine used to help adults manage their weight. Unlike weight loss injections such as Wegovy and Mounjaro, Mysimba is taken orally, swallowed with water every day.

Each prolonged-release Mysimba tablet contains two active ingredients: 8mg Naltrexone hydrochloride and 90mg Bupropion hydrochloride. These two medicines work together as a team to reduce hunger, control food cravings, and support weight loss (1).

How does Mysimba work?

Mysimba weight loss tablets act on areas of the brain involved in appetite and reward.

Bupropion and naltrexone are used separately in other medicines, including treatments for smoking cessation and alcohol or opioid dependence, because of their effects on these brain areas. But when used together, Mysimba for weight loss affects your:

  • Hunger: Hunger is the signal our brain receives to tell us that our body needs food. By reducing our hunger signals, Mysimba helps people feel satisfied with smaller portions, eat less, and snack less between meals.

  • Cravings: A craving is the desire for a specific type of food, even if not hungry. By affecting the reward system, Mysimba can help reduce the urge to respond to cravings and eat more healthily, without desires for bad foods getting in the way.

How long does Mysimba take to work?

Weight loss with Mysimba happens gradually. In clinical studies, the most significant weight loss was seen after 4 months (16 weeks) of taking Mysimba as prescribed (1-2).

Your response to treatment will be reviewed at this 16-week mark. If you have not lost at least 5% of your starting body weight after 16 weeks, Mysimba should be stopped as you are unlikely to benefit enough from continuing treatment (1).

How long does Mysimba last?

Every pack of Mysimba contains 112 tablets. How long these will last you depends on what stage of treatment you’re at.

  • Your first box will last 38 days (just over five weeks), because you start with one tablet a day and gradually increase your dose over the first four weeks (1).

  • After this, each pack lasts 28 days when taking the usual dose of four tablets a day.

Who is Mysimba for?

Mysimba tablets for weight loss are licensed in adults aged 18 and over who have (1):

  • a BMI of 30 or above, OR

  • a BMI of 27 or above and at least one weight-related health condition, such as type 2 diabetes, high cholesterol or controlled high blood pressure.

Unsure what your BMI is? Use this free NHS BMI calculator.

Because of how Mysimba works, it may be particularly worth considering if hunger or food cravings make it difficult for you to lose weight or stick to changes to your diet. For example, you might:

  • Feel hungry even after eating and find it hard to reduce portion sizes

  • Regularly experience food cravings or the urge to snack despite not being hungry

  • Eat to make yourself feel better when feeling stressed, lonely, or upset (emotional eating)

  • Have tried to lose weight before with a calorie-controlled diet and more exercise but need additional support to manage your weight

  • Would prefer an oral weight loss medication rather than a weekly injection

Whether Mysimba is right for you will also depend on your medical history and any other medicines you take. One of our clinicians will assess this as part of your consultation.

How effective is Mysimba?

Clinical trials show that Mysimba can help people lose more weight when combined with diet and exercise than diet and exercise alone (2,3).

In one 56-week clinical trial, people taking Naltrexone/Bupropion lost an average of 6.1% of their starting body weight, compared with 1.3% in the placebo group. Around 48% of people taking Naltrexone/Bupropion lost at least 5% of their starting weight (2).

However, diet and exercise are an important part of treatment. In another trial that included an intensive diet and exercise programme, people taking Mysimba lost an average of 9.3% of their starting weight over 56 weeks (3).

Of course, results from clinical trials cannot guarantee the results you see. You may end up losing more or less weight than this during treatment. Mysimba tablets should be stopped after 16 weeks if you have not lost at least 5% of your starting body weight (1).

Mysimba alternatives

If Mysimba weight loss tablets aren’t suitable for you, alternatives include:

  • Other weight loss tablets that reduce appetite: the Wegovy pill (oral Semaglutide) and Foundayo (Orforglipron) are GLP-1 weight loss pills. Unlike Mysimba, they mimic the effects of the GLP-1 hormone to help you feel fuller, reduce hunger and eat less.

Want more information? Read What Is The Wegovy Pill? and What Is Foundayo?.

  • Weight loss injections: Wegovy injections and Mounjaro are taken once a week and also work through appetite-regulating hormone pathways. Wegovy contains Semaglutide and mimics GLP-1, while Mounjaro contains Tirzepatide and acts on GIP and GLP-1 receptors.

Want to learn more? Read How Do Weight Loss Injections Work?

  • Tablets that reduce fat absorption: Weight loss tablets containing Orlistat as the active ingredient work differently from Mysimba and GLP-1 medicines. Instead of primarily reducing appetite, they reduce the amount of fat your body absorbs from the food you eat.

Which treatment is right for you depends on your BMI, health, other medicines, previous weight loss treatments and personal preferences. If you’re not sure where to start, our clinicians will advise you on the best weight loss treatment for your situation.

Mysimba Tablets (90mg) reviews

How to use Mysimba Tablets (90mg)

Mysimba tablets should preferably be taken with food and swallowed whole with water. Do not cut, chew or crush the tablets, as they are designed to release the medicine gradually (6).

Try to take Mysimba at around the same times each day, in both the morning and evening once you’re at the maintenance dose. If you forget a dose, skip it. Take your next dose at the normal time and don’t take extra tablets to make up for the missed one.

Mysimba dosage guide

The number of Mysimba tablets for weight loss that you need to take is gradually increased over the first four weeks of treatment (1):

  • Week 1: Take one tablet in the morning.

  • Week 2: Take one tablet in the morning and one in the evening.

  • Week 3: Take two tablets in the morning and one in the evening.

  • Week 4 onwards: Take two tablets in the morning and two in the evening.

The maximum recommended dose is four Mysimba weight loss tablets per day (1,6).

Your prescription label will explain how much Mysimba to take. Always follow the instructions provided by your prescriber and do not take more than the recommended dose.

How to store Mysimba

There are no special storage requirements for Mysimba weight loss tablets.

Keep them in their original packaging at room temperature (below 30°C) out of the sight and reach of children. Do not use the tablets past the expiry date shown on the medication box (6).

Side effects of Mysimba Tablets (90mg)

All medicines can cause side effects, although not everyone will get them. Below we’ve highlighted the most important Mysimba side effects, but this is not an exhaustive list.

Read the Mysimba Patient Information Leaflet for a complete list of all possible side effects.

Common Mysimba side effects

The most common side effects affecting more than 1 in 10 people who take Mysimba include (1):

  • Nausea

  • Constipation

  • Vomiting

While unpleasant, most people only experience mild digestive upset. These side effects are also often more noticeable when you first start Mysimba or while your dose is being increased, but quickly resolve themselves as the body gets used to the medicine.

Other common Mysimba side effects (affecting up to 1 in 10 people) include headache, dizziness, dry mouth, and difficulty sleeping, which also improve with continued treatment.

Serious side effects of Mysimba

Serious side effects are less common, but it is important to know what to look out for. Stop taking Mysimba and seek urgent medical help if you experience (6):

  • Thoughts about suicide or harming yourself, or other distressing thoughts

  • Fits or seizures

  • Problems with your vision, such as severe eye pain or changes in vision

  • Symptoms of a severe allergic reaction, e.g. difficulty swallowing or breathing and swelling of the face, tongue, mouth or throat

  • Signs of a severe skin reaction, such as a spreading rash, blistering or peeling skin, or sores or blisters affecting your mouth, eyes or genitals

  • Signs of liver problems, such as yellowing of the skin or whites of the eyes, dark urine, stomach area pain lasting more than a few days, and tiredness.

Mysimba warnings

If you have controlled high blood pressure or heart problems. You may still be able to take Mysimba, but it can increase your blood pressure and heart rate. Your clinician will check whether treatment is suitable, and your blood pressure and pulse should be monitored during treatment (1)

If you have depression or another mental health condition. You may still be able to take Mysimba, but tell us about any current or previous mental health problems before starting treatment. Seek advice straight away if you experience significant changes in your mood or behaviour (1).

If you have an increased risk of seizures. Certain factors, such as a previous head injury, low blood sugar or some medicines, can increase the risk of seizures. Tell your clinician about your medical history and any medicines you take so they can assess your risk before prescribing (1).

If you have type 2 diabetes. Losing weight can increase your risk of low blood sugar if you take insulin or certain other diabetes medicines. Your blood glucose should be monitored and your diabetes medication may need to be adjusted (1).

If you have kidney or liver problems. You may still be able to take Mysimba if you have mild or moderate kidney or liver impairment, but you may need a lower dose to reduce the risk of side effects. Tell us about any liver or kidney problems in your consultation (1).

Taking Mysimba with other medications

Mysimba can interact with other medicines. In your online consultation, tell us about all medicines you take, including prescription, over-the-counter and herbal medicines.

Do not take Mysimba with (1):

  • Monoamine oxidase inhibitors (MAOIs) often used to treat depression or Parkinson's disease, such as phenelzine, selegiline, or rasagiline. You must discontinue these drugs for at least 14 days before starting Mysimba.

  • Other medicines containing Bupropion or Naltrexone, such as Zyban. Mysimba already contains both of these active ingredients, so taking another medicine containing either of them could increase your risk of side effects, including seizures.

  • Long-term opioid medicines or opioid-dependence treatments, such as morphine or methadone. The naltrexone in Mysimba blocks the effects of opioids and can cause withdrawal in people who are dependent on them.

If you occasionally need an opioid medicine, such as for short-term pain relief, tell the healthcare professional treating you that you take Mysimba. You may need to temporarily stop Mysimba before taking the opioid, but this should be done under medical supervision.

Tell your physician if you take (1):

  • Medicines that can increase your risk of seizures, including some antidepressants and antipsychotics, antimalarials, systemic steroids, quinolone antibiotics, theophylline and sedating antihistamines

  • Antidepressants or other medicines for mental health conditions

  • Epilepsy medicines, including carbamazepine, phenytoin or valproate

  • Certain medicines for high blood pressure, including metoprolol

  • Some medicines for irregular heart rhythms, such as propafenone or flecainide

  • Certain cancer medicines, including tamoxifen, cyclophosphamide or ifosfamide

  • Parkinson's medicines, including levodopa or amantadine

  • Ticlopidine or clopidogrel

  • Certain HIV medicines, including efavirenz or ritonavir

  • Digoxin

Who should not take Mysimba?

Mysimba is not for everyone. Do NOT take Mysimba if you (1):

  • Are pregnant, planning to get pregnant, or breastfeeding

  • Have end-stage kidney failure

  • Have severe liver impairment

  • Have a history of bipolar disorder

  • Have uncontrolled high blood pressure

  • Have or have previously had seizures (fits)

  • Have or have previously had an eating disorder, such as anorexia or bulimia

  • Have a tumour of the central nervous system, such as a brain tumour

  • Are experiencing opioid withdrawal or take an opioid agonist like methadone

  • Are going through sudden withdrawal from alcohol, benzodiazepines or certain sedatives

  • Are allergic to Bupropion, Naltrexone or any of the ingredients in Mysimba

Frequently Asked Questions
Patient Information Leaflet

Important - Before taking any medication, it is always important to read the Patient Information Leaflet (PIL)

Mysimba Tablets (90mg) - Patient Information Leaflet

References
  1. Mysimba 8 mg/90 mg prolonged-release tablets - Summary of Product Characteristics (SmPC) - (emc) | 2684 [Internet]. Medicines.org.uk. 2025.

  2. Greenway FL, Fujioka K, Plodkowski RA, Mudaliar S, Guttadauria M, Erickson J, et al. Effect of naltrexone plus bupropion on weight loss in overweight and obese adults (COR-I): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial. Lancet (London, England) [Internet]. 2010 Spring;376(9741):595–605.

  3. Wadden TA, Foreyt JP, Foster GD, Hill JO, Klein S, O’Neil PM, et al. Weight Loss With Naltrexone SR/Bupropion SR Combination Therapy as an Adjunct to Behavior Modification: The COR-BMOD Trial. Obesity. 2011 Jan;19(1):110–20.

  4. NHS website. Orlistat [Internet]. nhs.uk. 2026 May.

  5. Alli 60 mg hard capsules - Summary of Product Characteristics (SmPC) - (emc) | 6533 [Internet]. Medicines.org.uk. 2025.

  6. Mysimba 8 mg/90 mg prolonged-release tablets - Patient Information Leaflet (PIL) - (emc) | 2684 [Internet]. Medicines.org.uk. 2025.

  7. NICE. Recommendations | Naltrexone–bupropion for managing overweight and obesity | Guidance | NICE [Internet]. www.nice.org.uk.

  8. Pi-Sunyer X, Apovian CM, McElroy SL, Dunayevich E, Acevedo LM, Greenway FL. Psychiatric adverse events and effects on mood with prolonged-release naltrexone/bupropion combination therapy: a pooled analysis. International Journal of Obesity. 2019 Jan 21;43(10):2085–94.

Message From Our Pharmacist

We recommend taking a multivitamin alongside your weight loss medication to ensure you get the necessary nutrients to support healthy weight loss. You can get Centrum Advanced multivitamin tablets here.

Related Weight Loss Articles
More...

Authored on September 22, 2026

Reviewed on September 26, 2026